SupplierPrice 
PDCD4 (Programmed Cell Death 4, Neoplastic Transformation Inhibitor, H731, MGC33046, MGC33047, Nuclear Antigen H731, OTTHUMP00000020483, Protein 197/15a, RP11 348N5.4)426€View
PDCD4 (Programmed Cell Death 4, Neoplastic Transformation Inhibitor, H731, MGC33046, MGC33047, Nuclear Antigen H731, OTTHUMP00000020483, Protein 197/15a, RP11 348N5.4)520€View
PDCD4 (Programmed Cell Death 4, Neoplastic Transformation Inhibitor, H731, MGC33046, MGC33047, Nuclear Antigen H731, OTTHUMP00000020483, Protein 197/15a, RP11 348N5.4) Antibody426€View
PDCD4 (Programmed Cell Death 4, Neoplastic Transformation Inhibitor, H731, MGC33046, MGC33047, Nuclear Antigen H731, OTTHUMP00000020483, Protein 197/15a, RP11 348N5.4) Antibody520€View
PFKFB3 (6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3, 6PF-2-K/Fru-2,6-P2ase 3, PFK/FBPase 3, 6PF-2-K/Fru-2,6-P2ase Brain/placenta-type Isozyme, FLJ37326, IPFK2, iPFK-2, PFK2, Renal Carcinoma Antigen NY-REN-56)619€View
PFKFB3 (6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3, 6PF-2-K/Fru-2,6-P2ase 3, PFK/FBPase 3, 6PF-2-K/Fru-2,6-P2ase Brain/placenta-type Isozyme, FLJ37326, IPFK2, iPFK-2, PFK2, Renal Carcinoma Antigen NY-REN-56) Antibody619€View
PIPMT (Cap-specific Guanine-N2 Methyltransferase, Nuclear Receptor Coactivator 6-interacting Protein, PRIP-interacting Protein With Methyltransferase Motif, PIMT, Trimethylguanosine Synthase, CLL-associated Antigen KW-2, Hepatocellular Carcinoma-associate619€View
PIPMT (Cap-specific Guanine-N2 Methyltransferase, Nuclear Receptor Coactivator 6-interacting Protein, PRIP-interacting Protein With Methyltransferase Motif, PIMT, Trimethylguanosine Synthase, CLL-associated Antigen KW-2, Hepatocellular Carcinoma-associate Antibody619€View
Platelet Derived Growth Factor Receptor, Type B, phosphorylated (Tyr857) (PDGF Receptor beta, PDGFRb, CD140b Antigen, JTK12, PDGFR1)625€View
Platelet Derived Growth Factor Receptor, Type B, phosphorylated (Tyr857) (PDGF Receptor beta, PDGFRb, CD140b Antigen, JTK12, PDGFR1) Antibody625€View
< Page: 124 >